|
2024-04-10 |
2024-04-08 |
B
Purchase
|
Wills Robert James
Non-Executive Director
|
3,086
+44.6%
8.96
USD 27,655
|
3,086
+44.6%
|
8.96
|
USD 27,655
|
|
|
2024-04-01 |
2024-03-28 |
B
Purchase
|
Wills Robert James
Non-Executive Director
|
6,914
+inf%
8.48
USD 58,602
|
6,914
+inf%
|
8.48
|
USD 58,602
|
|
|
2024-02-27 |
2024-02-23 |
S
Sale
|
Wills Robert James
Non-Executive Director
|
980
-100.0%
9.04
USD 8,859
|
980
-100.0%
|
9.04
|
USD 8,859
|
|
|
2024-02-27 |
2024-02-23 |
B
Purchase
|
HALE DAVID F
Non-Executive Director
|
266
+0.9%
9.04
USD 2,405
|
266
+0.9%
|
9.04
|
USD 2,405
|
|
|
2024-02-27 |
2024-02-23 |
B
Purchase
|
HALE DAVID F
Non-Executive Director
|
714
+inf%
9.04
USD 6,455
|
714
+inf%
|
9.04
|
USD 6,455
|
|
|
2023-06-14 |
2023-06-14 |
B
Purchase
|
Kaufmann Gunnar F.
Chief Scientific Officer
Officer
|
3,000
+3.3%
0.36
USD 1,079
|
3,000
+3.3%
|
0.36
|
USD 1,079
|
|
|
2023-06-14 |
2023-06-12 |
B
Purchase
|
Kaufmann Gunnar F.
Chief Scientific Officer
Officer
|
25,000
+37.5%
0.35
USD 8,745
|
25,000
+37.5%
|
0.35
|
USD 8,745
|
|
|
2023-04-17 |
2023-04-14 |
B
Purchase
|
BREITMEYER JAMES B
Chief Executive Officer
Executive Director
|
2,250
+1.2%
0.29
USD 653
|
2,250
+1.2%
|
0.29
|
USD 653
|
|
|
2023-04-17 |
2023-04-14 |
B
Purchase
|
BREITMEYER JAMES B
Chief Executive Officer
Executive Director
|
47,750
+32.6%
0.30
USD 14,277
|
47,750
+32.6%
|
0.30
|
USD 14,277
|
|
|
2023-04-14 |
2023-04-14 |
B
Purchase
|
Yazji Salim
Chief Medical Officer
Officer
|
5,000
+3.1%
0.30
USD 1,500
|
5,000
+3.1%
|
0.30
|
USD 1,500
|
|
|
2023-04-17 |
2023-04-13 |
B
Purchase
|
BREITMEYER JAMES B
Chief Executive Officer
Executive Director
|
100,000
+214.9%
0.29
USD 29,000
|
100,000
+214.9%
|
0.29
|
USD 29,000
|
|
|
2023-04-14 |
2023-04-13 |
B
Purchase
|
VINCENT RICHARD G
Chief Financial Officer
Officer
|
30,000
+23.6%
0.30
USD 8,961
|
30,000
+23.6%
|
0.30
|
USD 8,961
|
|
|
2023-04-14 |
2023-04-13 |
B
Purchase
|
Yazji Salim
Chief Medical Officer
Officer
|
10,000
+6.7%
0.29
USD 2,850
|
10,000
+6.7%
|
0.29
|
USD 2,850
|
|
|
2023-04-14 |
2023-04-13 |
B
Purchase
|
Leavitt Chase C.
General Counsel/Secretary
Officer
|
10,000
+10.3%
0.29
USD 2,900
|
10,000
+10.3%
|
0.29
|
USD 2,900
|
|
|
2023-04-14 |
2023-04-12 |
B
Purchase
|
Yazji Salim
Chief Medical Officer
Officer
|
10,000
+7.2%
0.29
USD 2,850
|
10,000
+7.2%
|
0.29
|
USD 2,850
|
|
|
2023-04-14 |
2023-04-12 |
B
Purchase
|
Leavitt Chase C.
General Counsel/Secretary
Officer
|
15,000
+18.3%
0.29
USD 4,350
|
15,000
+18.3%
|
0.29
|
USD 4,350
|
|
|
2022-03-28 |
2022-03-28 |
B
Purchase
|
VINCENT RICHARD G
Chief Financial Officer
Officer
|
2,500
+2.9%
1.40
USD 3,500
|
2,500
+2.9%
|
1.40
|
USD 3,500
|
|
|
2022-03-28 |
2022-03-25 |
B
Purchase
|
VINCENT RICHARD G
Chief Financial Officer
Officer
|
2,136
+2.6%
1.49
USD 3,182
|
2,136
+2.6%
|
1.49
|
USD 3,182
|
|
|
2022-03-28 |
2022-03-25 |
B
Purchase
|
VINCENT RICHARD G
Chief Financial Officer
Officer
|
5
+0.0%
1.48
USD 7
|
5
+0.0%
|
1.48
|
USD 7
|
|
|
2022-03-28 |
2022-03-25 |
B
Purchase
|
VINCENT RICHARD G
Chief Financial Officer
Officer
|
356
+0.4%
1.45
USD 516
|
356
+0.4%
|
1.45
|
USD 516
|
|
